These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 24071024)
1. Characterizing lobular carcinoma of the male breast using the SEER database. Moten A; Obirieze A; Wilson LL J Surg Res; 2013 Dec; 185(2):e71-6. PubMed ID: 24071024 [TBL] [Abstract][Full Text] [Related]
2. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ. Wong SM; King T; Boileau JF; Barry WT; Golshan M Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673 [TBL] [Abstract][Full Text] [Related]
3. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001. Li CI; Malone KE; Saltzman BS; Daling JR Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564 [TBL] [Abstract][Full Text] [Related]
4. Synchronous lobular carcinoma in situ and invasive lobular cancer: marker or precursor for invasive lobular carcinoma. Wallace AS; Xiang D; Hockman L; Arya M; Jeffress J; Wang Z; Dale PS Eur J Surg Oncol; 2014 Oct; 40(10):1245-9. PubMed ID: 24857380 [TBL] [Abstract][Full Text] [Related]
5. Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma? Jayasinghe UW; Bilous AM; Boyages J Breast J; 2007; 13(5):479-85. PubMed ID: 17760669 [TBL] [Abstract][Full Text] [Related]
6. Gender differences in breast cancer: analysis of 13,000 breast cancers in men from the National Cancer Data Base. Greif JM; Pezzi CM; Klimberg VS; Bailey L; Zuraek M Ann Surg Oncol; 2012 Oct; 19(10):3199-204. PubMed ID: 22766989 [TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma. Shah C; Wilkinson JB; Shaitelman S; Grills I; Wallace M; Mitchell C; Vicini F Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e547-51. PubMed ID: 21640491 [TBL] [Abstract][Full Text] [Related]
8. Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period. Fortunato L; Mascaro A; Poccia I; Andrich R; Amini M; Costarelli L; Cortese G; Farina M; Vitelli C Ann Surg Oncol; 2012 Apr; 19(4):1107-14. PubMed ID: 21913022 [TBL] [Abstract][Full Text] [Related]
9. The Pathologic Finding of Combined Lobular Carcinoma Jean-Louis CJ; Masdon J; Smith B; Battles O; Dale P Am Surg; 2017 May; 83(5):482-485. PubMed ID: 28541858 [TBL] [Abstract][Full Text] [Related]
10. Male breast cancer: a retrospective analysis. Yoney A; Kucuk A; Unsal M Cancer Radiother; 2009 Apr; 13(2):103-7. PubMed ID: 19250851 [TBL] [Abstract][Full Text] [Related]
11. Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis. Fields EC; DeWitt P; Fisher CM; Rabinovitch R Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):747-52. PubMed ID: 24138917 [TBL] [Abstract][Full Text] [Related]
12. Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade. Metzger-Filho O; Ferreira AR; Jeselsohn R; Barry WT; Dillon DA; Brock JE; Vaz-Luis I; Hughes ME; Winer EP; Lin NU Oncologist; 2019 Jul; 24(7):e441-e449. PubMed ID: 30518616 [TBL] [Abstract][Full Text] [Related]
13. The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology. Moran MS; Yang Q; Haffty BG Breast J; 2009; 15(6):571-8. PubMed ID: 19995377 [TBL] [Abstract][Full Text] [Related]
14. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma. Vo TN; Meric-Bernstam F; Yi M; Buchholz TA; Ames FC; Kuerer HM; Bedrosian I; Hunt KK Am J Surg; 2006 Oct; 192(4):552-5. PubMed ID: 16978974 [TBL] [Abstract][Full Text] [Related]
15. Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years. Li CI; Moe RE; Daling JR Arch Intern Med; 2003 Oct; 163(18):2149-53. PubMed ID: 14557212 [TBL] [Abstract][Full Text] [Related]
16. Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers. Bharat A; Gao F; Margenthaler JA Am J Surg; 2009 Oct; 198(4):516-9. PubMed ID: 19800459 [TBL] [Abstract][Full Text] [Related]
17. Male breast cancers behave differently in elderly patients. Tural D; Selçukbiricik F; Aydoğan F; Beşe N; Yetmen O; Ilvan Ş; Büyükünal E; Serdengeçti S Jpn J Clin Oncol; 2013 Jan; 43(1):22-7. PubMed ID: 23159765 [TBL] [Abstract][Full Text] [Related]
18. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. Chuba PJ; Hamre MR; Yap J; Severson RK; Lucas D; Shamsa F; Aref A J Clin Oncol; 2005 Aug; 23(24):5534-41. PubMed ID: 16110014 [TBL] [Abstract][Full Text] [Related]
19. In situ male breast carcinoma in the Surveillance, Epidemiology, and End Results database of the National Cancer Institute. Anderson WF; Devesa SS Cancer; 2005 Oct; 104(8):1733-41. PubMed ID: 16138363 [TBL] [Abstract][Full Text] [Related]
20. Racial/ethnic differences in survival rates in a population-based series of men with breast carcinoma. O'Malley CD; Prehn AW; Shema SJ; Glaser SL Cancer; 2002 Jun; 94(11):2836-43. PubMed ID: 12115370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]